scholarly journals A Canadian paediatric brain tumour consortium (CPBTC) phase II molecularly targeted study of imatinib in recurrent and refractory paediatric central nervous system tumours

2009 ◽  
Vol 45 (13) ◽  
pp. 2352-2359 ◽  
Author(s):  
Sylvain Baruchel ◽  
Julia R. Sharp ◽  
Ute Bartels ◽  
Juliette Hukin ◽  
Isaac Odame ◽  
...  
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
Brain Tumour ◽  
Phase Ii ◽  
Central Nervous System Tumours ◽  
Paediatric Brain Tumour

Central nervous system atypical teratoid rhabdoid tumours: The Canadian Paediatric Brain Tumour Consortium experience

2012 ◽  
Vol 48 (3) ◽  
pp. 353-359 ◽  
Author(s):  
L. Lafay-Cousin ◽  
C. Hawkins ◽  
A.S. Carret ◽  
D. Johnston ◽  
S. Zelcer ◽  
...  
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
Brain Tumour ◽  
Atypical Teratoid ◽  
Paediatric Brain Tumour

scholarly journals 55 Malignant primary brain and other central nervous system tumours diagnosed in the Canadian population from 2009 to 2013

2018 ◽  
Vol 45 (S3) ◽  
pp. S16-S17
Author(s):  
EV Walker ◽  
F Davis ◽  
Keyword(s):  
United States ◽  
Central Nervous System ◽  
Nervous System ◽  
Brain Tumour ◽  
Age Distribution ◽  
Paediatric Population ◽  
The United States ◽  
Incidence Rates ◽  
Canadian Population ◽  
Cns Tumours

The Canadian Brain Tumour Registry (CBTR) project was established in 2016 with the aim of enhancing infrastructure for surveillance and clinical research to improve health outcomes for brain tumour patients in Canada. We present a national surveillance report on malignant primary brain and central nervous system (CNS) tumours diagnosed in the Canadian population from 2009-2013. Patients were identified through the Canadian Cancer Registry (CCR); an administrative dataset that includes cancer incidence data from all provinces/territories in Canada. Cancer diagnoses are coded using the ICD-O3 system. Tumour types were classified by site and histology using The Central Brain Tumour Registry of the United States definitions. Incidence rates (IR) and 95% confidence intervals (CI) were calculated per 100,000 person-years and standardized to the 2011 census population age-distribution. Overall, 12,115 malignant brain and CNS tumours were diagnosed in the Canadian population from 2009-2013 (IR:8.43;95%CI:8.28,8.58). Of these, 6,845 were diagnosed in males (IR:9.72;95%CI:9.49,9.95) and 5,270 in females (IR:7.20;95%CI:7.00,7.39). The most common histology overall was glioblastoma (IR:4.06;95%CI:3.95,4.16). Among those aged 0-19 years, 1,130 malignant brain and CNS tumours were diagnosed from 2009-2013 (IR:3.36;95%CI:3.16,3.56). Of these, 625 were diagnosed in males (IR:3.32;95%CI:3.34,3.92) and 505 in females (IR:3.08;95%CI:2.81,3.36). The most common histology among the paediatric population was pilocytic astrocytoma (IR:0.73;95%CI:0.64,0.83). The presentation will include: IRs for other histologies, the geographic distribution of cases and a comparison between Canada and the United States.

Multidisciplinary treatment for central nervous system tumours with nitrosourea compounds

1978 ◽  
Vol 41 (4) ◽  
pp. 287-299 ◽  
Author(s):  
P. Paoletti ◽  
G. Robustelli della Cuna ◽  
R. Knerich ◽  
M. R. Strada
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
Multidisciplinary Treatment ◽  
Central Nervous System Tumours
Sign in / Sign up

Export Citation Format

Share Document